BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous autoinjector (SC-AI) as a weekly starting ...
The U.S. FDA approved Merck & Co. Inc.’s Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection on Sept. 19, making it the first and only subcutaneously (SC)-administered immune ...
South Carolina's execution chamber. (Provided/SC Department of Corrections) COLUMBIA — The state’s law keeping information about lethal injection drugs secret violates constitutional rights to free ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果